• 1 800 260 6682
  • GTranslate

Other ways to reach us: 1.800.260.6682 | 902.424.8670 | info@investnovascotia.ca

  • ABK Biomedical Announces FDA 510(k) Clearance for Easi-Vue Embolic Microspheres

ABK Biomedical Announces FDA 510(k) Clearance for Easi-Vue Embolic Microspheres

Monday, September 12, 2022

ABK Biomedical, an Innovacorp portfolio company, has announced FDA 510(k) clearance of Easi-Vue embolic microspheres for the treatment of patients suffering from arteriovenous malformations and hypervascular tumors. Read ABK's press release.

September 12, 2022, Halifax, Nova Scotia